Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 463 entries
Sorted by: Best Match Show Resources per page
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 18985183
Methods Find Exp Clin Pharmacol. 2008 Sep;30(7):543-88.

Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2008;30(7):543-88
Tomillero, A., & Moral, M. A. (2008). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 30(7), 543-88.
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 30,7 (2008): 543-88.
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2008 Sep;30(7):543-88. PMID: 18985183.
Copy Download .nbib Format: NLM
Effects of long-term administration of lithium and hydrochlorothiazide in rats.

Metal-based drugs

Loghin F, Olinic A, Popa DS, Socaciu C, Leucuta SE.
PMID: 18475886
Met Based Drugs. 1999;6(2):87-93. doi: 10.1155/MBD.1999.87.

The biochemical and histological changes following 60 days administration of daily doses equivalent to 1/20 LD(50) of lithium lactate and hydrochlorothiazide, as such and in association, were studied in male Wistar rats. No mortality or overt signs of toxicity...

Cite
Loghin F, Olinic A, Popa DS, et al. Effects of long-term administration of lithium and hydrochlorothiazide in rats. Met Based Drugs. 1999;6(2):87-93doi: 10.1155/MBD.1999.87.
Loghin, F., Olinic, A., Popa, D. S., Socaciu, C., & Leucuta, S. E. (1999). Effects of long-term administration of lithium and hydrochlorothiazide in rats. Metal-based drugs, 6(2), 87-93. https://doi.org/10.1155/MBD.1999.87
Loghin, F, et al. "Effects of long-term administration of lithium and hydrochlorothiazide in rats." Metal-based drugs vol. 6,2 (1999): 87-93. doi: https://doi.org/10.1155/MBD.1999.87
Loghin F, Olinic A, Popa DS, Socaciu C, Leucuta SE. Effects of long-term administration of lithium and hydrochlorothiazide in rats. Met Based Drugs. 1999;6(2):87-93. doi: 10.1155/MBD.1999.87. PMID: 18475886; PMCID: PMC2365157.
Copy Download .nbib Format: NLM
A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285].

Current controlled trials in cardiovascular medicine

Pater C, Bhatnagar D, Berrou JP, Luszick J, Beckmann K.
PMID: 15461784
Curr Control Trials Cardiovasc Med. 2004 Oct 01;5(1):9. doi: 10.1186/1468-6708-5-9.

Hypertension and diabetes mellitus are closely interrelated and coexist in as many as two-thirds of patients with type 2 diabetes. The consequent risk of such an association is an accelerated development of atherosclerotic cardiovascular disease and nephropathy complications.In choosing...

Cite
Pater C, Bhatnagar D, Berrou JP, et al. A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Curr Control Trials Cardiovasc Med. 2004;5(1):9doi: 10.1186/1468-6708-5-9.
Pater, C., Bhatnagar, D., Berrou, J. P., Luszick, J., & Beckmann, K. (2004). A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Current controlled trials in cardiovascular medicine, 5(1), 9. https://doi.org/10.1186/1468-6708-5-9
Pater, Cornel, et al. "A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]." Current controlled trials in cardiovascular medicine vol. 5,1 (2004): 9. doi: https://doi.org/10.1186/1468-6708-5-9
Pater C, Bhatnagar D, Berrou JP, Luszick J, Beckmann K. A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Curr Control Trials Cardiovasc Med. 2004 Oct 01;5(1):9. doi: 10.1186/1468-6708-5-9. PMID: 15461784; PMCID: PMC524514.
Copy Download .nbib Format: NLM
Episodic muscle tremors in a quarter horse: resemblance to hyperkalemic periodic paralysis.

The Canadian veterinary journal = La revue veterinaire canadienne

Steiss JE, Naylor JM.
PMID: 17422693
Can Vet J. 1986 Sep;27(9):332-5.

A three year old Quarter Horse stallion was presented with a one year history of episodes of generalized muscle tremors and stiffness, and spasm of the muscles of facial expression, lasting 10-15 minutes. Between attacks, the horse was either...

Cite
Steiss JE, Naylor JM. Episodic muscle tremors in a quarter horse: resemblance to hyperkalemic periodic paralysis. Can Vet J. 1986;27(9):332-5
Steiss, J. E., & Naylor, J. M. (1986). Episodic muscle tremors in a quarter horse: resemblance to hyperkalemic periodic paralysis. The Canadian veterinary journal = La revue veterinaire canadienne, 27(9), 332-5.
Steiss, J E, and Naylor, J M. "Episodic muscle tremors in a quarter horse: resemblance to hyperkalemic periodic paralysis." The Canadian veterinary journal = La revue veterinaire canadienne vol. 27,9 (1986): 332-5.
Steiss JE, Naylor JM. Episodic muscle tremors in a quarter horse: resemblance to hyperkalemic periodic paralysis. Can Vet J. 1986 Sep;27(9):332-5. PMID: 17422693; PMCID: PMC1680300.
Copy Download .nbib Format: NLM
Determination of fosinopril in pharmaceutical formulations containing hydrochlorothiazide by multiwavelength UV spectrophotometry.

Talanta

Magri' AL, Balestrieri F, Magri' AD, Marini D.
PMID: 18966407
Talanta. 1995 Nov;42(11):1719-23. doi: 10.1016/0039-9140(95)01642-2.

A sensitive, simple, rapid and precise method for the simultaneous determination of fosinopril (FOS) and hydrochlorothiazide (HCT) in pharmaceutical formulations is presented. These active ingredients are extracted in aqueous solution and measured by multiwavelength UV spectrophotometry using the program...

Cite
Magri' AL, Balestrieri F, Magri' AD, et al. Determination of fosinopril in pharmaceutical formulations containing hydrochlorothiazide by multiwavelength UV spectrophotometry. Talanta. 1995;42(11):1719-23doi: 10.1016/0039-9140(95)01642-2.
Magri', A. L., Balestrieri, F., Magri', A. D., & Marini, D. (1995). Determination of fosinopril in pharmaceutical formulations containing hydrochlorothiazide by multiwavelength UV spectrophotometry. Talanta, 42(11), 1719-23. https://doi.org/10.1016/0039-9140(95)01642-2
Magri', A L, et al. "Determination of fosinopril in pharmaceutical formulations containing hydrochlorothiazide by multiwavelength UV spectrophotometry." Talanta vol. 42,11 (1995): 1719-23. doi: https://doi.org/10.1016/0039-9140(95)01642-2
Magri' AL, Balestrieri F, Magri' AD, Marini D. Determination of fosinopril in pharmaceutical formulations containing hydrochlorothiazide by multiwavelength UV spectrophotometry. Talanta. 1995 Nov;42(11):1719-23. doi: 10.1016/0039-9140(95)01642-2. PMID: 18966407.
Copy Download .nbib Format: NLM
Valsartan: the past, present and future.

Future cardiology

Køber L, Torp-Pedersen C.
PMID: 19804097
Future Cardiol. 2005 Sep;1(5):591-8. doi: 10.2217/14796678.1.5.591.

Valsartan (Diovan) is a widely use angiotensin receptor blocker that prevents angiotensin II from binding to the subtype 1 receptor. Stimulation of the subtype 1 receptor is believed to mediate many of the deleterious effects accompanied by increased angiotensin...

Cite
Køber L, Torp-Pedersen C. Valsartan: the past, present and future. Future Cardiol. 2005;1(5):591-8doi: 10.2217/14796678.1.5.591.
Køber, L., & Torp-Pedersen, C. (2005). Valsartan: the past, present and future. Future cardiology, 1(5), 591-8. https://doi.org/10.2217/14796678.1.5.591
Køber, Lars, and Torp-Pedersen, Christian. "Valsartan: the past, present and future." Future cardiology vol. 1,5 (2005): 591-8. doi: https://doi.org/10.2217/14796678.1.5.591
Køber L, Torp-Pedersen C. Valsartan: the past, present and future. Future Cardiol. 2005 Sep;1(5):591-8. doi: 10.2217/14796678.1.5.591. PMID: 19804097.
Copy Download .nbib Format: NLM
Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets.

Indian journal of pharmaceutical sciences

Bhusari KP, Khedekar PB, Dhole S, Banode VS.
PMID: 20502567
Indian J Pharm Sci. 2009 Sep;71(5):505-8. doi: 10.4103/0250-474X.58176.

Two methods for simultaneous estimation of hydrochlorothiazide and olmesartan medoxomil in combined tablet dosage form have been developed. The first method is the application of Q-analysis method (absorbance ratio), which involves the formation of Q-absorbance equation at 264 nm...

Cite
Bhusari KP, Khedekar PB, Dhole S, et al. Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets. Indian J Pharm Sci. 2009;71(5):505-8doi: 10.4103/0250-474X.58176.
Bhusari, K. P., Khedekar, P. B., Dhole, S., & Banode, V. S. (2009). Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets. Indian journal of pharmaceutical sciences, 71(5), 505-8. https://doi.org/10.4103/0250-474X.58176
Bhusari, K P, et al. "Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets." Indian journal of pharmaceutical sciences vol. 71,5 (2009): 505-8. doi: https://doi.org/10.4103/0250-474X.58176
Bhusari KP, Khedekar PB, Dhole S, Banode VS. Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets. Indian J Pharm Sci. 2009 Sep;71(5):505-8. doi: 10.4103/0250-474X.58176. PMID: 20502567; PMCID: PMC2866340.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayes M, Rabasseda X, Prous JR.
PMID: 18040531
Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):547-83.

(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869, Adalimumab, Ad-rh Endostatin, AI-700, Alemtuzumab, Alvimopan hydrate, Amrubicin hydrochloride, AP-12009, Apomab 7.3, Arformoterol tartrate, Aripiprazole, AS-1404, Azacitidine, AZD-0530; Bevacizumab, BHT-3009, Biapenem, Bortezomib, Bosentan, Bremelanotide; CA9-SCAN, Calcitonin gene-related peptide,...

Cite
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007;29(8):547-83
Bayes, M., Rabasseda, X., & Prous, J. R. (2007). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 29(8), 547-83.
Bayes, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 29,8 (2007): 547-83.
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):547-83. PMID: 18040531.
Copy Download .nbib Format: NLM
Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania.

Cost effectiveness and resource allocation : C/E

Robberstad B, Hemed Y, Norheim OF.
PMID: 17316431
Cost Eff Resour Alloc. 2007 Feb 22;5:3. doi: 10.1186/1478-7547-5-3.

BACKGROUND: There is a high and rising prevalence of cardiovascular risk in sub-Saharan Africa, a development typical for countries in epidemiological transition. Contrary to recommendations in treatment guidelines, medical interventions to prevent cardiovascular disease are implemented only on a...

Cite
Robberstad B, Hemed Y, Norheim OF. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania. Cost Eff Resour Alloc. 2007;5:3doi: 10.1186/1478-7547-5-3.
Robberstad, B., Hemed, Y., & Norheim, O. F. (2007). Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania. Cost effectiveness and resource allocation : C/E, 53. https://doi.org/10.1186/1478-7547-5-3
Robberstad, Bjarne, et al. "Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania." Cost effectiveness and resource allocation : C/E vol. 5 (2007): 3. doi: https://doi.org/10.1186/1478-7547-5-3
Robberstad B, Hemed Y, Norheim OF. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania. Cost Eff Resour Alloc. 2007 Feb 22;5:3. doi: 10.1186/1478-7547-5-3. PMID: 17316431; PMCID: PMC1808049.
Copy Download .nbib Format: NLM
Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant.

Journal of dermatological case reports

Heelan K, Ryan JF, Shear NH, Egan CA.
PMID: 24421864
J Dermatol Case Rep. 2013 Dec 30;7(4):113-20. doi: 10.3315/jdcr.2013.1157. eCollection 2013.

BACKGROUND: Wells syndrome is an uncommon inflammatory dermatosis first described in 1971 by Wells. The clinical eruption is characterized by varying morphology and severity and usually follows a relapsing remitting course. The majority of the reported cases are of...

Cite
Heelan K, Ryan JF, Shear NH, et al. Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep. 2013;7(4):113-20doi: 10.3315/jdcr.2013.1157.
Heelan, K., Ryan, J. F., Shear, N. H., & Egan, C. A. (2013). Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant. Journal of dermatological case reports, 7(4), 113-20. https://doi.org/10.3315/jdcr.2013.1157
Heelan, Kara, et al. "Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant." Journal of dermatological case reports vol. 7,4 (2013): 113-20. doi: https://doi.org/10.3315/jdcr.2013.1157
Heelan K, Ryan JF, Shear NH, Egan CA. Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep. 2013 Dec 30;7(4):113-20. doi: 10.3315/jdcr.2013.1157. eCollection 2013. PMID: 24421864; PMCID: PMC3888780.
Copy Download .nbib Format: NLM
Stability studies of the effect of crosslinking on hydrochlorothiazide release.

Drug discoveries & therapeutics

Elmeshad AN, Darwish MK.
PMID: 22495541
Drug Discov Ther. 2009 Jun;3(3):136-42.

The aim of this study was to determine the changes in the in vitro drug release from cross-linked hard gelatin capsules containing a water-insoluble drug. An immediate release hydrochlorothiazide (HCTZ) capsule formulations containing drug, lactose, starch 1500 were prepared...

Cite
Elmeshad AN, Darwish MK. Stability studies of the effect of crosslinking on hydrochlorothiazide release. Drug Discov Ther. 2009;3(3):136-42
Elmeshad, A. N., & Darwish, M. K. (2009). Stability studies of the effect of crosslinking on hydrochlorothiazide release. Drug discoveries & therapeutics, 3(3), 136-42.
Elmeshad, A N, and Darwish, M K. "Stability studies of the effect of crosslinking on hydrochlorothiazide release." Drug discoveries & therapeutics vol. 3,3 (2009): 136-42.
Elmeshad AN, Darwish MK. Stability studies of the effect of crosslinking on hydrochlorothiazide release. Drug Discov Ther. 2009 Jun;3(3):136-42. PMID: 22495541.
Copy Download .nbib Format: NLM
A new spectrophotometric method for the determination of methyldopa.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Gadkariem EA, Ibrahim KE, Kamil NA, Haga ME, El-Obeid HA.
PMID: 23960712
Saudi Pharm J. 2009 Oct;17(4):289-93. doi: 10.1016/j.jsps.2009.10.005. Epub 2009 Nov 10.

A new, simple and low cost spectrophotometric method for the determination of methyldopa in pharmaceutical preparations was developed. The method was based on the coupling of methyldopa with 2,6-dichloroquinone-4-chlorimide (DCQ). The absorbance maximum (λ max) of the resulted colored...

Cite
Gadkariem EA, Ibrahim KE, Kamil NA, et al. A new spectrophotometric method for the determination of methyldopa. Saudi Pharm J. 2009;17(4):289-93doi: 10.1016/j.jsps.2009.10.005.
Gadkariem, E. A., Ibrahim, K. E., Kamil, N. A., Haga, M. E., & El-Obeid, H. A. (2009). A new spectrophotometric method for the determination of methyldopa. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 17(4), 289-93. https://doi.org/10.1016/j.jsps.2009.10.005
Gadkariem, E A, et al. "A new spectrophotometric method for the determination of methyldopa." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 17,4 (2009): 289-93. doi: https://doi.org/10.1016/j.jsps.2009.10.005
Gadkariem EA, Ibrahim KE, Kamil NA, Haga ME, El-Obeid HA. A new spectrophotometric method for the determination of methyldopa. Saudi Pharm J. 2009 Oct;17(4):289-93. doi: 10.1016/j.jsps.2009.10.005. Epub 2009 Nov 10. PMID: 23960712; PMCID: PMC3730969.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 463 entries